Results 31 to 40 of about 5,604 (216)

Dysphagia During Pharyngeal and Esophageal Phase of Seronegative Immune-Mediated Necrotizing Myopathy: A Case Report. [PDF]

Cureus
Takaku N, Hayashi K, Suzuki A, Nakaya Y, Sato M, Miura T, Nishino I, Kobayashi Y.   +7 more
europepmc   +3 more sources

A tough pill to swallow: Two cases of statin-induced necrotizing autoimmune myopathy manifesting as dysphagia and transaminitis

SAGE Open Medical Case Reports, 2023
Although 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors are well tolerated, a small subset of patients may develop autoimmune myopathy, classified as immune-mediated necrotizing myopathy.
Hunza Chaudhry, Joanne Lin, Rameen Atefi, Jeffrey Hagino, Candice Marie Yuvienco, Marina Roytman   +5 more
doaj   +1 more source

Anti-3-hydroxy-3-methylglutaryl coenzyme A reductase immune-mediated necrotizing myopathy with a CD68+ lymphohistiocytic cutaneous eruption. [PDF]

JAAD Case Rep
Park Y, Finan CF, Elwood H, Konstantinov NK.   +3 more
europepmc   +2 more sources

Severe Anti-HMG-CoAR Necrotizing Autoimmune Myopathy Secondary to Statin Use

Case Reports in Rheumatology, 2022
Immune-mediated necrotizing myopathy is an uncommon but debilitating disease that can be triggered by drugs, toxins, or cancer. It is similar to polymyositis in presentation but is differentiated by findings on muscle biopsy.
Priyanjali Pulipati, Jayakar Kamantha Reddy, Syed Ali Husain   +2 more
doaj   +1 more source

The myokine GDF-15 is a potential biomarker for myositis and associates with the protein aggregates of sporadic inclusion body myositis. [PDF]

, 2020
Background: The cytokine growth differentiation factor-15 (GDF-15) has been associated with inflammatory and mitochondrial disease, warranting exploration of its expression in myositis patients.
De Bleecker, Jan, De Paepe, Boel, Verhamme, Fien   +2 more
core   +2 more sources

A Case Report of Statin-Induced Immune-Mediated Necrotizing Myopathy Treatment Challenges

Case Reports in Rheumatology, 2022
Statin-induced necrotizing autoimmune myopathy is an immune-mediated necrotizing myopathy related to the use of statins. It is a very rare disease, which usually presents with proximal muscle weakness and frank elevation in creatine kinase levels ...
Anwar I. Joudeh, Mhd Kutaiba Albuni, Sara Seife Hassen, Phool Iqbal, Elsaid Mohamed Aziz Bedair, Salah Mahdi   +5 more
doaj   +1 more source

Efgartigimod combined with steroids as a fast-acting therapy for anti-SRP immune-mediated necrotizing myopathy [PDF]

Front Neurol
Qiqi Peng, Xiaoping Yao, Sheng Chen, Xiaofeng Li, Feifei Lin, Zhang‐Yu Zou   +5 more
europepmc   +2 more sources

Effectiveness of proprotein convertase subtilisin/kexin type 9 inhibitors in managing hypercholesterolemia post-statin-associated immune-mediated necrotizing myopathy: report of five cases and literature review. [PDF]

Rheumatol Int
Yerolatsite M, Torounidou N, Gerolymatou N, Panteli A, Koletsos N, Karakosta M, Zarkavelis G, Voulgari PV.   +7 more
europepmc   +2 more sources

Statin-associated anti-HMGCR immune-mediated necrotizing myopathy with dermatomyositis-like features: A case report

SAGE Open Medical Case Reports, 2020
Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) immune-mediated necrotizing myopathy is a subtype of idiopathic inflammatory myopathy which may be associated with statin exposure.
Darosa Lim, Océane Landon-Cardinal, Benjamin Ellezam, Annie Belisle, Annie Genois, Jennifer Sirois, Josiane Bourré-Tessier   +6 more
doaj   +1 more source

Peculiar clinicopathological features of immune-mediated necrotizing myopathies [PDF]

Current Opinion in Rheumatology, 2018
Purpose of reviewIn the past decade, immune-mediated necrotizing myopathies have emerged as a separate entity in the heterogenous group of autoimmune myopathies. This group is characterized by clinical manifestations restricted to the muscle tissue, and until recently, the definition was based on muscular pathological features.Recent findingsIt was ...
Allenbach, Yves, Benveniste, Olivier
openaire   +4 more sources